Table 3.
HR of three statin groups in NODM.
| Independent Variables | Crude-HR (95% CI) | p-Value | Adj-HR (95% CI) # | p-Value |
|---|---|---|---|---|
| Comparison 1 | 0.038 | 0.230 | ||
| Pitavastatin | 1.00 | 1.00 | ||
| Atorvastatin | 1.21 (1.02–1.44) | 0.032 | 1.04 (0.87–1.25) | 0.677 |
| Rosuvastatin | 1.24 (1.05–1.47) | 0.011 | 1.13 (0.94–1.35) | 0.196 |
| Comparison 2 | ||||
| Pitavastatin | 1.00 | 1.00 | ||
| Atorvastatin/Rosuvastatin | 1.23 (1.05–1.45) | 0.012 | 1.09 (0.91–1.29) | 0.356 |
#: All results of Adj-HR were adjusted by years, gender, age, coronary artery disease, hypertension, chronic obstructive pulmonary disease, chronic kidney disease, cancer, ischemic stroke, hemorrhagic stroke, heart failure. Adj-HR: adjusted hazard ratio; CI: confidence interval; HR: hazard ratio; NODM: new-onset diabetes mellitus; years: years before and after the release of pitavastatin.